GAMCO Investors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

GAMCO Investors’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,000	Closed	-$263K	–	949
2020 Q4	$263K	Buy	+2,000	New	+$177K	﹤0.01%	815

GAMCO Investors's EIDX Position: Q1 2021 in Review

GAMCO Investors sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 2,000 shares — an estimated $263K sold.

GAMCO Investors first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $263K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

GAMCO Investors reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
GAMCO Investors sold 2,000 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $263K.
GAMCO Investors first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
GAMCO Investors's Eidos Therapeutics, Inc. Common Stock position peaked at $263K in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on GAMCO Investors's 13F filing for Q1 2021, filed 14 May 2021.